A tailor-made zootechnical additive based on bacteriophage technology capable of inhibiting the growth of E. coli strains associated with avian colibacillosis, as well as helping to enhance the effectiveness of antibiotic therapy in specific geographic territories.
FÓRMIDA contains specific bacteriophages against Escherichia coli.
Proven Results:
More resilient birds: reduces clinical signs of colibacillosis by 42%.
Fewer lesions: reduces the presence of lesions associated with aerosaculitis and pericarditis in birds by 76% when administered alongside conventional treatments against APEC.
Complementary Action: reduces the prevalence of colibacillosis by 50% when paired with conventional treatments.
A laboratory study published in 2024 analyzed 142 E. coli isolates collected from broiler farms in Brazil and classified them using APECtyper into four pathotypes: APEC, High-Risk (HR) APEC, HR non-APEC, and non-APEC. Remarkably, over 60 % of the isolates carried genes associated with resistance to at least three antibiotic classes, underscoring the urgency for a targeted antimicrobial solution.
